Immuno 101 By Steve|2024-10-11T16:12:20+13:00July 16th, 2019|Categories: All, Immunotherapy, Z-Legacy|Tags: dmmr, immunotherapy, MSI, Pdl, terminologies, tmb, Trial Patient| Read More 2
Treatment options improving for Cholangiocarcinoma By Steve|2024-10-11T16:12:25+13:00October 15th, 2018|Categories: All, Immunotherapy, Z-Legacy|Tags: ABC-02, ARID1A, BAP1, BAY1436032, BRAF, BRCA1/2, Chemotherapy, Cyramza, dmmr, EGFR, epigenetic, FGFR2, Gem/Cis, GENOME, HER2 amplification, IDH1, IDH1/2, immunotherapy, Kelly, KEYNOTE-158, Keytruda, Lynparza, MEK, MET, MMR, olaparib, Oncologists, ramucirumab, TAS-120, TP53, treatment, TreeTopp, VEGFR, VEGFR2| Read More 0
Simplifying Immunotherapy terminology By Steve|2024-10-11T16:12:57+13:00September 15th, 2018|Categories: Archived, Z-Legacy|Tags: dmmr, Education, How, immunotherapy, Keytruda, MSI-H, Opdivo, PD-1 Checkpoint inhibitors, PD-L1, Terminology| Read More 1
Cholangiocarcinoma Treatment lmproving By Steve|2024-10-11T16:13:34+13:00August 15th, 2018|Categories: All, Clinical Trials, Immunotherapy, Z-Legacy|Tags: ARID1A, BRCA1/2, dmmr, HER2 amplification, Keytruda, Pembrolizumab, TP53| Read More 2